Dilon highlights RSNA MBI research

By AuntMinnie.com staff writers
December 4, 2012

Breast-specific gamma imaging (BSGI) provider Dilon Diagnostics is highlighting research presented at the RSNA 2012 show that suggests molecular breast imaging (MBI) with the company's BSGI technology can detect breast cancer missed by mammography.

Dr. Rachel Brem from George Washington University Medical Center presented clinical data from a study that included 364 high-risk patients. All of the women had had a recent negative mammogram and then underwent an MBI examination with the firm's BSGI system. MBI detected breast cancer in nine patients of this cohort, all of whom had dense breasts, Dilon said.

If you like this content, please share it with a colleague!

Related Reading

Dilon touts low-dose breast imaging results
Breast-specific gamma imaging provider Dilon Diagnostics said that new research shows its gamma camera can perform molecular breast imaging at half of...

Dilon promotes declipseSPECT study results
Breast-specific gamma imaging developer Dilon Diagnostics is highlighting clinical research regarding its declipseSPECT device presented in March at the...

Dilon touts BSGI research from NCBC
Dilon Diagnostics is directing attention to a recent multicenter patient registry that found that its BSGI technology improves breast cancer detection...

Dilon highlights BSGI study results
Breast-specific gamma imaging (BSGI) developer Dilon Diagnostics is pointing to results of a study that concluded that BSGI can detect cancers missed...

Dilon to distribute SurgicEye products
Breast-specific gamma imaging developer Dilon Diagnostics has become the exclusive distributor of SurgicEye's intraoperative soft-tissue imaging and navigation...

Copyright © 2012 AuntMinnie.com